Malin Pedersen

4.1k citations

37 papers · 2.4k indexed · 1 hit paper · h-index 22

Impact in

Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
Immunology top 5%
- Immunotherapy and Immune Responses
- interferon and immune responses

Papers in

Immunology 15
- interferon and immune responses 5
- Immunotherapy and Immune Responses 5
Oncology 16
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 4

Co-authors: Kevin J. Harrington Martin McLaughlin Magnus T. Dillon Alan Melcher Emmanuel C. Patin Anna Wilkins Richard Marais Lars Rönnstrand
Journals: Cancer Research (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Cancer Discovery (3 papers)Nature (2 papers)Frontiers in Oncology (2 papers)
Partner nations: United Kingdom United States Sweden

In The Last Decade

Malin Pedersen

35 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Inflammatory microenvironment remodelling by tumour cells after radiotherapy 2020 · 601 citations

Peers

Countries citing papers authored by Malin Pedersen

Since Specialization

Citations

This map shows the geographic impact of Malin Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malin Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malin Pedersen more than expected).

Fields of papers citing papers by Malin Pedersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malin Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malin Pedersen. The network helps show where Malin Pedersen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Malin Pedersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Malin Pedersen Line = papers co-authored together Malin Pedersen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ARID1A stabilizes non-homologous end joining factors at DNA breaks induced by the G4 ligand pyridostatin Cell Reports ·Susana Simoes‐Sousa, Najaf Amin, Geovges Delaume, Alison Harrod, Malin Pedersen, Mercedes Pardo, Christine Rasetti‐Escargueil, Rao Ailun, Katheryn Begg, Alison Ribeiro, Susana Banerjee, Manuel Stucki, Kevin J. Harrington, Jyoti S. Choudhary, Jessica A. Downs	2025	0
2	Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer Cancer Research Communications ·Charleen Chan Wah Hak, Emmanuel C. Patin, 元本田, Annalisa Nicastri, Rao Ailun, Ruth Northway, Joan Kyula, Victoria Roulstone, Feng Wen, 오연옥, Tencho Tenev, Elizabeth Appleton, 肖业炎, Shane Foo, Malin Pedersen, Jyoti S. Choudhary, Masahiro Ono, Alan Melcher, Antonio Rullan, Kevin J. Harrington	2025	0
3	Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity Journal for ImmunoTherapy of Cancer ·Andrew Hayes, Emma Jane Davies, Michelle Wilkinson, Henry Smith, Pablo Nenclares, Tom Lund, Adrian Lärkeryd, Elizabeth Appleton, Emmanuel C. Patin, Malin Pedersen, Antonio Rullan, Шутенко Владимир Витальевич, Lauren I. Aronson, А. А. Шумаєв, Lorna Grove, David Mansfield, Martin McLaughlin, Kevin J. Harrington, Alan Melcher	2025	1
4	Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling Journal for ImmunoTherapy of Cancer ·Férecheté Razavi, 서호복, Shane Foo, 雅彦荒木, Pablo Nenclares, 元本田, María del Valle López Martínez, Martin McLaughlin, Nitika Sharma, Kwang-Hyun 이광현Lee, Victoria Roulstone, Emmanuel C. Patin, Malin Pedersen, Joan Kyula, Masahiro Ono, Fiona Errington‐Mais, John C. Bell, Kevin J. Harrington, Alan Melcher, Victoria A. Jennings	2024	5
5	Characterization of proteome-size scaling by integrative omics reveals mechanisms of proliferation control in cancer Science Advances ·Ian Jones, 眞齊藤, Tomoaki Higo, Theodoros I. Roumeliotis, Mar Arias-García, H. C., Jyoti S. Choudhary, Malin Pedersen, Chris Bakal	2023	7
6	Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy Frontiers in Oncology ·Pedro M. Cabrera-Castillo, Antonio Rullan, Emmanuel C. Patin, Malin Pedersen, Alan Melcher, Kevin J. Harrington	2022	23
7	Inflammatory microenvironment remodelling by tumour cells after radiotherapy Nature reviews. Cancer ·Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, Anna Wilkins, Magnus T. Dillon, Alan Melcher, Kevin J. Harrington Hit paper breakdown →	2020	601
8	Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer Journal for ImmunoTherapy of Cancer ·Zong Qing Lu, Katharina Bergerhoff, Nitika Sharma, Shane Foo, Emmanuel C. Patin, 高原典子, Richard Buus, Syed Haider, Gareth Muirhead, Khin Thway, Kate Newbold, Robert S. Coffin, Richard G. Vile, Dae Joon Kim, Martin McLaughlin, Alan Melcher, Kevin J. Harrington, Malin Pedersen	2020	24
9	The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism Molecular Therapy — Oncolytics ·Martin McLaughlin, Malin Pedersen, Victoria Roulstone, Katharina Bergerhoff, Henry Smith, 高原典子, Joan Kyula, Magnus T. Dillon, Hardev Pandha, Richard G. Vile, Alan Melcher, Kevin J. Harrington	2020	24
10	ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment Clinical Cancer Research ·Magnus T. Dillon, Katharina Bergerhoff, Malin Pedersen, 高原典子, Zong Qing Lu, Emmanuel C. Patin, Alex Pearson, Henry Smith, James Paget, Radhika Patel, Shane Foo, Nitika Sharma, Chanthirika Ragulan, Elisa Fontana, Krisha Desai, Anna Wilkins, Anguraj Sadanandam, Alan Melcher, Martin McLaughlin, Kevin J. Harrington	2019	146
11	Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei Molecular Cancer Therapeutics ·Magnus T. Dillon, Holly E. Barker, Malin Pedersen, Hind Hafsi, Shreerang Bhide, Kate Newbold, Christopher M. Nutting, Martin McLaughlin, Kevin J. Harrington	2016	82
12	BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress Molecular Therapy ·Victoria Roulstone, Malin Pedersen, Joan Kyula, David Mansfield, Aadil Khan, 真美河内, Michelle Wilkinson, Eleni Karapanagiotou, Matt Coffey, Richard Marais, Adel Jebar, Fiona Errington‐Mais, Alan Melcher, Richard G. Vile, Hardev Pandha, Martin McLaughlin, Kevin J. Harrington	2015	38
13	A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity Nature Communications ·L. R. Bristow, Gwendoline Gros, Christine Longvert, Malin Pedersen, Valérie Petit, Zackie Aktary, Amaya Virós, Franck Gesbert, Véronique Delmas, Florian Rambow, Boris C. Bastian, Andrew D. Campbell, Sophie Colombo, Isabel Puig, Alfonso Bellacosa, Owen J. Sansom, Richard Marais, Léon C.L.T. van Kempen, Lionel Larue	2015	55
14	Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes Cancer Discovery ·Malin Pedersen, Heidi V.N. Küsters‐Vandevelde, Amaya Virós, Patricia J.T.A. Groenen, Berta Sanchez‐Laorden, Amanzhan Abubakirov, Edith Thomson, W.O. Renier, Jolanda Schieving, Ion Niculescu‐Duvaz, Caroline J. Springer, Benno Küsters, Pieter Wesseling, Willeke A.M. Blokx, Richard Marais	2013	51
15	Abstract 3404: Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma. Cancer Research ·María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden, Amaya Virós, Samra Turajlic, Dan Niculescu‐Duvaz, Alfonso Zambon, John Sinclair, Andrew Hayes, Martin Gore, Caroline J. Springer, James Larkin, Claus Jørgensen, Richard Marais	2013	1
16	Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma Cancer Discovery ·María Romina Girotti, Malin Pedersen, Berta Sanchez‐Laorden, Amaya Virós, Samra Turajlic, Dan Niculescu‐Duvaz, Alfonso Zambon, John Sinclair, Andrew Hayes, Martin Gore, Paul Lorigan, Caroline J. Springer, James Larkin, Claus Jørgensen, Richard Marais	2012	272
17	The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction Journal of Biological Chemistry ·Jianmin Sun, Malin Pedersen, Lars Rönnstrand	2009	59
18	Stem cell factor induces HIF-1α at normoxia in hematopoietic cells Biochemical and Biophysical Research Communications ·Malin Pedersen, Tobias Löfstedt, Jianmin Sun, Linda Holmquist Mengelbier, Sven Påhlman, Lars Rönnstrand	2008	59
19	The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit Cellular Signalling ·Malin Pedersen, Lars Rönnstrand, J Miguel Hernandez-Hierro	2008	21
20	Gab2 Is Involved in Differential Phosphoinositide 3-Kinase Signaling by Two Splice Forms of c-Kit Journal of Biological Chemistry ·Jianmin Sun, Malin Pedersen, Lars Rönnstrand	2008	47

About Malin Pedersen

Malin Pedersen is a scholar working on Immunology, Oncology, Biotechnology, Dermatology and Molecular Biology, having authored 37 papers that have together received 2.4k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (7 papers), Virus-based gene therapy research (6 papers), interferon and immune responses (5 papers), Immunotherapy and Immune Responses (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), CAR-T cell therapy research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Oncology (1.1k citations), Immunology (673 citations), Cancer Research (293 citations), Molecular Biology (1.3k citations) and Ophthalmology (164 citations). Malin Pedersen has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Kevin J. Harrington, Martin McLaughlin, Magnus T. Dillon, Alan Melcher, Emmanuel C. Patin, Anna Wilkins, Richard Marais, Lars Rönnstrand, Jianmin Sun and Samra Turajlic. Their work appears in journals such as Cancer Research, Journal for ImmunoTherapy of Cancer, Cancer Discovery, Nature and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact